Key result
Reprogramming crRNA-tracrRNA interactions enables repurposing endogenous RNAs into sequence-specific biosensors for SARS-CoV-2 detection.
Why the study?
Although tracrRNAs are diverse in sequence and structure across type II CRISPR systems, the programmability of crRNA-tracrRNA hybridization for Cas9 is not fully understood.
Reprogramming tracrRNAs expands the capabilities of Cas9 systems, enabling novel RNA biosensors for applications such as viral RNA detection.
May enable CRISPR-based RNA biosensors; leaves open in vivo validation and clinical translation.
In type II CRISPR systems, the guide RNA (gRNA) comprises a CRISPR RNA (crRNA) and a hybridized trans-acting CRISPR RNA (tracrRNA), both being essential in guided DNA targeting functions. Although tracrRNAs are diverse in sequence and structure across type II CRISPR systems, the programmability of crRNA-tracrRNA hybridization for Cas9 is not fully understood. Here, we reveal the programmability of crRNA-tracrRNA hybridization for Streptococcus pyogenes Cas9, and in doing so, redefine the capabilities of Cas9 proteins and the sources of crRNAs, providing new biosensing applications for type II CRISPR systems. By reprogramming the crRNA-tracrRNA hybridized sequence, we show that engineered crRNA-tracrRNA interactions can not only enable the design of orthogonal cellular computing devices but also facilitate the hijacking of endogenous small RNAs/mRNAs as crRNAs. We subsequently describe how these re-engineered gRNA pairings can be implemented as RNA sensors, capable of monitoring the transcriptional activity of various environment-responsive genomic genes, or detecting SARS-CoV-2 RNA in vitro, as an Atypical gRNA-activated Transcription Halting Alarm (AGATHA) biosensor.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2022) studied this question. Reprogrammed tracrRNAs (AGATHA biosensor) vs. Wild-type tracrRNA was evaluated on RNA sensing capability (fluorescence output). Reprogramming crRNA-tracrRNA interactions enables the repurposing of endogenous RNAs as crRNAs and the creation of sequence-specific RNA biosensors, such as AGATHA for SARS-CoV-2 detection.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: